Image Courtesy: www.breastcancer.org

Researchers at the Penn State Cancer Research Institute have received $7.5 million from the Susan G. Komen for the Cure Research Program to look at ways to reduce high breast density, a risk factor for breast cancer.

Specifically, the study is examining the effect omega 3 essential fatty acids and of a low dose of antiestrogen medications on high breast density.

The grant, given through Komen's Promise Grants, is one of the largest awarded by Komen for the Cure.

The four-year study includes both clinical trials and animal research, according to Dr. Andrea Manni, one of two researchers heading up the project at the Cancer Institute.

Image Courtesy: www.probio.no

The human part of the study includes five experimental arms involving different dosages of Raloxifene (Evista), an antiestrogen; Lovaza, a prescription dietary supplement of omega-3 fatty acids approved by the Food and Drug Administration; and a combination of the two.

Source:
The Patriot-News
Tuesday July 14, 2009